Sangamo Therapeutics (SGMO) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $523000.0.
- Sangamo Therapeutics' Receivables - Net fell 9501.71% to $523000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $523000.0, marking a year-over-year decrease of 9501.71%. This contributed to the annual value of $526000.0 for FY2024, which is 4301.19% down from last year.
- According to the latest figures from Q3 2025, Sangamo Therapeutics' Receivables - Net is $523000.0, which was down 9501.71% from $372000.0 recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Receivables - Net ranged from a high of $10.5 million in Q3 2024 and a low of $366000.0 during Q1 2025
- Moreover, its 5-year median value for Receivables - Net was $3.7 million (2022), whereas its average is $3.9 million.
- Per our database at Business Quant, Sangamo Therapeutics' Receivables - Net soared by 81428.57% in 2024 and then crashed by 9501.71% in 2025.
- Quarter analysis of 5 years shows Sangamo Therapeutics' Receivables - Net stood at $6.0 million in 2021, then plummeted by 38.47% to $3.7 million in 2022, then tumbled by 75.05% to $923000.0 in 2023, then plummeted by 43.01% to $526000.0 in 2024, then fell by 0.57% to $523000.0 in 2025.
- Its Receivables - Net stands at $523000.0 for Q3 2025, versus $372000.0 for Q2 2025 and $366000.0 for Q1 2025.